Dudediligence.

Hemab Therapeutics Holdings, Inc

COAGNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeSep 24 →Insiders6 insiders bought $55.5M in 16 open-market buys. No sales.→HoldersRa 16.7%Novo Holdings A/S 9.0%FMR 7.9%→Financing →

From the filings

Figures

Cash and equivalents
$237.4Mat the last balance sheet
Shares outstanding
46.7M shareson issue
Every year and quarter →